PART 2- Understanding the Complexities U.S. Drug Price Contracting
PART 2- Understanding the Complexities U.S. Drug Price Contracting
There has been a ton of talk about the need for “transparent pricing,” as well as controlling the cost of drugs in the US. There seems to be a lot of finger pointing going on and it often looks like the providers and the manufacturers are taking a lot of the heat…!?
Our special guest today is Antonio Ciaccia, Chief Strategy Officer and Co-Founder, of 3 Axis Advisors. I had the privilege of hearing Antonio speak at a recent Midwest Business Group on Health webinar, and I asked Antonio to please help us understand the complexities of the drug distribution channel and how this system can really muddy the waters in our pursuit of more transparency in this segment of the healthcare system.
Please note that the views and opinions expressed by the guest(s) on this episode, are those of the guest(s), and do not necessarily represent the official policy or position of The Kinetix Group and our staff, clients, or customers.
www.TKGOncology.com